Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 48,000 BOLD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Boundless Bio, Inc. (BOLD) | Grant/Award | 48,000 | n/a |
| Jun 10, 2026 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| Jan 30, 2026 | Erasca, Inc. (ERAS) | Grant/Award | 2,000,000 | n/a |
| Sep 24, 2025 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 18,000 | n/a |
| Jun 23, 2025 | Boundless Bio, Inc. (BOLD) | Grant/Award | 24,000 | n/a |
| Feb 5, 2025 | Erasca, Inc. (ERAS) | Grant/Award | 2,500,000 | n/a |
| Feb 4, 2025 | Maze Therapeutics, Inc. (MAZE) | Conversion | 37,724 | n/a |
| Jun 21, 2024 | Erasca, Inc. (ERAS) | Grant/Award | 632,759 | n/a |
| Jun 20, 2024 | Boundless Bio, Inc. (BOLD) | Grant/Award | 6,610 | n/a |
| Apr 4, 2024 | Boundless Bio, Inc. (BOLD) | Conversion | 525,274 | n/a |